This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Link between effectiveness and cost data
The costing was undertaken retrospectively (patient billing) on the same patient sample as that used in the effectiveness study.
Study sample
A cohort of 128 patients was included in the analysis. Seventy-one patients (Group I) were admitted for elective infrarenal AoIS before the day of surgery without any identifiable medical reasons to prepare them for operation (mean age: 70.1 years, 73% male, 92% Caucasian, 17% retroperitoneal incision, 65% epidural analgesia). Fifty-seven patients (Group II) were admitted on the day of surgery (mean age: 68.3 years, 70% male, 93% Caucasian, 27% retroperitoneal incision, 91% epidural analgesia). Power calculations to determine the sample size were not undertaken.
Study design
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Nonrandomized trial with concurrent controls. The duration of the follow-up was not stated. There was no loss to followup.
Analysis of effectiveness
The analysis of the clinical study was based on intention to treat. The primary health outcomes were mortality rate, rate of complications, total length of hospital stay, length of stay in the intensive care unit and readmission rate within 30 days of discharge.
Effectiveness results
The mortality rate was 0% in both groups (p>0.05). The complication rates (p>0.05) for Groups I and II were: cardiac 1.4 versus 0%, pulmonary 9.9% versus 5.3%
and renal 1.4% versus 0% .
The total length of hospital stay was 6.4 versus 11.2 days for Groups I and II respectively (p<0.0001). The length of stay in the intensive care unit was 1.2 days for Group I versus 2.3 days for Group II (p<0.0001). The readmission rates within 30 days of discharge were 5.6% versus 5.2% for Groups I and II respectively (p>0.05).
Clinical conclusions
Patients who require elective infrarenal AoIS can be admitted the day of surgery without increase in morbidity and mortality rates.
Measure of benefits used in the economic analysis
No single summary benefit measure was determined. As the intervention and comparator had statistically similar outcomes, the main benefit was reduction of costs (cost-minimization).
Direct costs
Hospital costs were included in the analysis. The quantities were analysed separately from the prices. The quantity/cost boundary adopted was the hospital. Discounting was not undertaken due to the short period of follow-up. The price year was not stated.
